Park Circle Company’s Anixa Biosciences ANIX Stock Holding History

Park Circle Company’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$1.65K	–	53
2025 Q3	$1.65K	Hold	500	–	–	﹤0.01%	68
2025 Q2	$1.65K	Hold	500	–	–	﹤0.01%	114
2025 Q1	$1.43K	Hold	500	–	–	﹤0.01%	109
2024 Q4	$1.16K	Hold	500	–	–	﹤0.01%	107
2024 Q3	$1.57K	Hold	500	–	–	﹤0.01%	105
2024 Q2	$1.1K	Hold	500	–	–	﹤0.01%	112
2024 Q1	$1.56K	Hold	500	–	–	﹤0.01%	105
2023 Q4	$1.94K	Hold	500	–	–	﹤0.01%	111
2023 Q3	$1.64K	Buy	+500	New	+$1.75K	﹤0.01%	108

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Park Circle Company's ANIX Position: Q4 2025 in Review

Park Circle Company sold out of Anixa Biosciences (ANIX) in Q4 2025, closing a stake of 500 shares — an estimated $1.65K sold.

Park Circle Company first reported a position in ANIX in Q3 2023 and held it in 9 quarters. The position peaked at $1.94K in Q4 2023. 71 funds tracked by Wall St. Rank hold ANIX as of Q4 2025.

Park Circle Company reported no remaining Anixa Biosciences position as of Q4 2025 after selling out during the quarter.
Park Circle Company sold 500 Anixa Biosciences shares in Q4 2025, an estimated $1.65K.
Park Circle Company first reported a position in Anixa Biosciences in Q3 2023 and held it in 9 quarters.
Park Circle Company's Anixa Biosciences position peaked at $1.94K in Q4 2023.
71 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2025.

Based on Park Circle Company's 13F filing for Q4 2025, filed 13 Feb 2026.